Our @TU_SP student posters are at 10:00 AM PST tomorrow, and @TUHSPharmRes showcase is in the afternoon from 1 to 4pm! Stop by!
Fun fact: Apparently the Temple mascot has a name. Hooter the Owl! ๐ฆ๐ฆ
KDIGO has released a new resource for clinicians treating patients with #diabetes and #CKD. Check out the KDIGO Diabetes in CKD Quick Reference Guide: https://t.co/oiWHKEi2uH
The Diabetes in CKD Quick Reference Guide presents recommendation statements from each chapter of the KDIGO 2022 Diabetes Management in CKD Guideline in an infographic-style format. It is designed to be printed or downloaded for easy reference.
Use finerenone in ckd with t2d if k at most 5 and egfr >25. Don't stop till k 5.5. Expect a fifth reduction in dialysis and more than a fifth reduction in heart failure on top of ace or arb. Key is to start when egfr preserved to mitigate risk of hyperK
@jclem1027@ACCP@RxWritersUnite Have you ever tried using https://t.co/Yr9akvqqvX?
As a new practitioner, I've found it to be a pretty great place to start!
Would โค๏ธโค๏ธ to see other tips/tricks!
For a small pool of pharmacists specializing in nephrology, they certainly play an outsize role in patient care and med care. More are needed https://t.co/x4eBpaQmy8
Core Curriculum by Sheryl F. Vondracek, Isaac Teitelbaum, and Tyree H. Kiser:
Principles of Kidney Pharmacotherapy for the Nephrologist
https://t.co/zEXdhYXAm3 (FREE)
@Tiniagliptin Was JUST talking about this w a colleague...I sometimes wonder if it'd be easier if I looked older or were male?
Regardless, no pearls from me - just encouragement: You've done difficult things (& had hard convos) before. You can do it! โค๏ธโค๏ธ
Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion
๐https://t.co/NtxNs4oy76
๐ธProposal for anticoagulant strategy in HD patients with AF